US 12157735
Compounds for targeted degradation of BRD9
granted A61KA61K45/06A61P
Quick answer
US patent 12157735 (Compounds for targeted degradation of BRD9) held by C4 THERAPEUTICS, INC. expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00